Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Ultrasound-guided pain relief for heart procedures

Official title: Analgesic Effect of Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Femoral Endovascular Cardiac Interventions: A Prospective-randomized Study

Run by Istanbul University - Cerrahpasa · NCT06576128 · Data updated 2026-11-12

This study is testing if using ultrasound to guide a specific pain relief technique can make heart procedures more comfortable for patients.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorIstanbul University - Cerrahpasa
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedSeptember 10, 2024
Main results expectedOctober 15, 2027
Study endsDecember 15, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT06576128 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years undergoing elective coronary angiography, cardiac catheterization, or percutaneous coronary intervention.

Probably not a fit

Patients under 18, those requiring emergency procedures, or individuals with certain medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of ultrasound-guided transversus abdominis plane (TAP) block to provide analgesia during endovascular cardiac interventions such as coronary angiography and cardiac catheterization. By targeting specific nerve branches that innervate the femoral region, the study aims to enhance patient comfort and satisfaction during these procedures. The study will assess both patient and physician satisfaction levels, contributing to a better understanding of pain management in cardiac interventions.

Why it matters

Potential benefit: If successful, this approach could significantly improve pain management and patient satisfaction during cardiac procedures.

How similar studies have gone: While the use of TAP blocks in other surgical fields has shown promise, this specific application in cardiac interventions is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The patient is over 18 years of age
* Coronary angiography, cardiac catheterization and percutaneous coronary intervention will be applied to the patient,
* The above-mentioned procedures will be taken under elective conditions,
* Providing an optimal image when imaging the patient with ultrasound,
* INR\< 1.5
* If the patient gives consent, S/he will be included in the study.

Exclusion Criteria:

* Patients under 18 years of age,
* Patients treated under emergency conditions,
* morbid obesity (BMI\>35 kg/m2),
* pregnant women,
* New York Heart Association (NYHA) stage 4 patients with advanced decompensated heart failure,
* Patients with symptoms such as redness, temperature increase, infection, hematoma in the application area before the procedure,
* Patients with a history of allergy to local anesthetics,
* Patients who cannot be communicated,
* Those with severe psychosis or progressive neurological deficits and muscle disease,
* Patients who do not consent to the application will be excluded from the study.

Where it's running

  • Istanbul University- Cerrahpasa
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.